Tumor cells from the tumor cell line PC9 (HLA-A2+ EGFR mutant NSCLC) were either cocultured with PBMCs in their native state or after stimulation with IFN-γ and TNF-α to increase antigen presentation. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.